DBV Technologies (DBVT) Gains from Investment Securities (2020 - 2025)
DBV Technologies (DBVT) reported Gains from Investment Securities of $1.2 million for Q4 2025, up 83.48% year-over-year from $672000.0 in Q4 2024, and up 10375.0% quarter-over-quarter from -$12000.0 in Q3 2025.
DBV Technologies (DBVT) Gains from Investment Securities (2020 - 2025) Analysis & Trends
DBV Technologies (DBVT) has 6 years of Gains from Investment Securities data on file, last reported at $1.2 million in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $1.2 million, up 83.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $719000.0 (up 242.38% YoY), and the FY2025 annual result was $219000.0, up 7200.0% from the prior year.
- Gains from Investment Securities advanced to $1.2 million in Q4 2025 per DBVT's latest filing, from -$12000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.2 million in Q4 2025 and troughed at -$2.1 million in Q3 2021.
- A 5-year average of -$30000.0 and a median of $3000.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2025: Gains from Investment Securities jumped 800.0% in 2021, then plunged 6350.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $558000.0 in 2021, then tumbled by 99.28% to $4000.0 in 2022, then tumbled by 675.0% to -$23000.0 in 2023, then jumped by 3021.74% to $672000.0 in 2024, then surged by 83.48% to $1.2 million in 2025.
- Business Quant data shows DBVT's Gains from Investment Securities at $1.2 million in Q4 2025, -$12000.0 in Q3 2025, and -$502000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.23 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -502,000.00 |
| Jun 30, 2025 | -502,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Mar 31, 2025 | -500,000.00 |
| Dec 31, 2024 | 672,000.00 |
| Dec 31, 2024 | 672,000.00 |
| Sep 30, 2024 | -636,000.00 |
| Sep 30, 2024 | -636,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |